missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Visilizumab Recombinant Monoclonal Antibody
Recombinant Monoclonal Antibody
Marke: Invitrogen™ MA559208
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Visilizumab is a biosimilar that targets CD3E. It has been investigated for the treatment of Ulcerative Colitis.
Spezifikation
| Visilizumab Humanized | |
| Recombinant Monoclonal | |
| Unconjugated | |
| HuM291 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG2SA |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Human | |
| 1 mg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction